Alaa Khedr Ph.D . Professor Faculty of Pharmacy King Abdulaziz University
description
Transcript of Alaa Khedr Ph.D . Professor Faculty of Pharmacy King Abdulaziz University
Alaa Khedr Ph.D. Professor
Faculty of PharmacyKing Abdulaziz University
E-mail: [email protected] R
الرحيم الرحمن الله بسممحمد سيدنا على وسلم صلي اللهم
STABILITY STUDY and EXPIRATION DATE
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
AbbreviationsAPI Active Pharmaceutical Ingredient FDC Fixed-Dose CombinationFPP Finished Pharmaceutical Product GMP Good Manufacturing PracticesICH International Conference on HarmonizationMA Marketing AuthorizationDRA Drug Regulatory Authority MCA: Medicine Control AgencyFDA: Food and Drug Administration NDA: New Drug ApplicationsANDA: Abbreviated New Drug ApplicationsEU: European Union EMEA: European Medicinal Evaluation Agency CPMP: Committee for Proprietary Medicinal ProductsNTA: Notices To ApplicantCDER / CFR: Code of Federal Register
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Applicable guidelines• Guidance for Industry
Q1A(R2) Stability Testing of New Drug Substances and ProductsU.S. Department of Health and Human ServicesFood and Drug AdministrationCenter for Drug Evaluation and Research (CDER)Center for Biologics Evaluation and Research (CBER)November 2003, ICH
• Guidance for IndustryQ1E Evaluation of Stability DataU.S. Department of Health and Human ServicesFood and Drug AdministrationCenter for Drug Evaluation and Research (CDER)Center for Biologics Evaluation and Research (CBER)June 2004, ICH
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
1- The purpose of stability testing is to provide evidence on how the quality of a drug substance or drug product varies with time under the influence of a variety of environmental factors such as temperature, humidity and light, and enables recommended (1) storage conditions, (2) re-test periods and (3) shelf lives to be established.
Objectives
Drug100%
Drug 95.5%
+Time(month)
Temp.HumidityLight
2- Safety and efficacy.
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Specification of ProductAll SOP’s
Drug product
Equipment & tools
Reference Standards
Stability Indicating Analytical Method
Design
Written/Approved
IQ/OQ/PQ, Data LoggerLog sheets
Compendia& Company SpcsApproved Docs
ICH Stress testingDevelopmentValidationRepresent. Chromatograms
Batch size3 batchesSampling protocol
Purchase USP / Europ. RSPurchase Potential ImpuritiesStorage cabinetVerified
Before starting program execution we should have;
Stability Protocol
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Design
Written/Approved
Before starting program execution we should have;
Stability Protocol
Who doing what? How to do the taskClear interpretation of proceduresStepwise manner
1
Stability protocol is a signed/dated and approved document that describe the exact and clear procedure to start the stability testing of drug. The procedure should be described in a sequential stepwise manner, who doing what, how to do the task.
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Specification of ProductAll SOP’s
Design Before starting program execution we should have;
Info. Source 1 = Compendia (USP/BP)Info. Source 2 = FDA / ICH guidelines (Limits / general Official Procedure)Info. Source 3 = Supplier of raw materialInfo. Source 4 = Company approved specs of API and PFP
2
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Equipment & tools
Design
IQ/OQ/PQ, Data LoggerLog sheets
Before starting program execution we should have;
Documentations are available = IQ/OQ/PQData Logger (calibrated) = Temp., HumidityDocuments = Log sheets of operation, time, dateHow to operate the machine = SOP for machine
3
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Stability Cabinets
+ Data loggers !!!!
HPLC
Dissolution
UV
Karl Fisher
BalancesCalibrated Glassware
Equipment & tools3
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
1. A special cabinet for each condition
2. Should be qualified / calibrated3. Monitor Temp. / humidity vs time.
Time4. Three General conditions
required.
Stability Cabinets
Data loggers
Deep freeze
+ Data loggers !!!!Equipment & tools3
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Data Loggers (Types)
sensor probe / thermocouple
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Why we use Data Loggers ?How many sensor probe?How to position sensors?
1. To monitor Both, temperature and Relative Humidity along 24 hours.
2. To ensure consistency of the adjusted Temp. and RH.3. Should be calibrated by supplier4. Any deviation for NLT 6 hours, we should stop study
and repeat using new samples.5. Ex: Electricity shutdown, or instrument failer, no enough
water inside instrument.
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Why we defined some products to be photosensitive, to which degree ?
(use UV-A, 200 watts hours/m2 )Illumination : 1.2 million Lux hoursHumidity range : 40% to 95% ± 2% RHTemperature range : 100c to 500C, ± 0.50C
-- Use calibrated machine (candles/inch = ?) 3. Exposure time limit = ?(according to the limit of potential degradation
products formed, and quinine HCl standard)
Photostability CabinetsAt least one primary batch Should be tested
Equipment & tools3
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Stability Indicating Analytical Method
Design
ICH Stress testingDevelopmentValidationRepresent. Chromatograms
Before starting program execution we should have;
4
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Stability indicating Analytical MethodThe method is able to discriminate between principle drugand the degradation products and/or impurities
Method: Compendial methods are claimed to be stability indicatingRules: ICH stress Guideline Plus: Photodegradation products & reconstitution testingMonitoring: Peaks of Potential impurities & Degradation products (previously define the cause)
AU
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
Minutes10.00 20.00 30.00
12.3
08
21.3
68
28.0
5329
.170
30.5
44
Sta
bilit
y S
tudy
and
Exp
iratio
n da
teFl
uore
scen
ce
0.00
10.00
20.00
11.2
54
14.2
44
15.1
74
Dan
-BET
- 18
.413
19.8
07
20.9
13
Fluo
resc
ence
0.00
10.00
20.00
11.2
73
14.2
53
Dan
-BE
T -
18.4
20
19.8
12
20.9
17
Fluo
resc
ence
0.00
10.00
20.0011
.274
14.2
61
Dan
-BET
- 18
.421
19.8
12
Fluo
resc
ence
0.00
10.00
20.00
7.16
6 9.78
6
10.8
1111
.272
12.8
71
15.1
8815
.875
Dan
-BET
- 18
.414
19.8
10
21.8
70
Fluo
resc
ence
0.00
10.00
20.00
11.2
71
14.2
61
Dan
-BET
- 18
.423
19.8
1420
.173
20.9
11
Fluo
resc
ence
0.00
10.00
20.00
Minutes0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00
11.2
21
14.4
9115
.234
18.4
53
19.8
42
Rules of Stress testing:-- expose drug subs. To abnormal environmental variables.-- Forced degradation to NLT 90%.-- Do not degraded the drug completely ? To provide selectivity of the method.
Example of STRESS TESTING OF BETAHISTINE HCl
Representative chromatograms of betahistine hydrochloride; heated in solid state [a], boiled in 1M NaOH [b], boiled with 1M HCl [c], extracted from tablet powder exposed to UV light [d], extracted from Betaserc tablets [e], and left to stand in 0.1% H2O2 solution [f].
heated
NaOH
HCl
UV light
Betaserc tablets
H2O2
Sta
bilit
y S
tudy
and
Exp
iratio
n da
teAU
0.000
0.010
0.020
0.030
0.040
0.050
0.060
0.070
0.080
Minutes10.00 20.00 30.00
12.4
86
AU
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
Minutes10.00 20.00 30.00
12.3
08
21.3
68
28.0
5329
.170
30.5
44
Chromatographic parameters* of TIA degraded with 1M HCl, (detection; UV at 254 nm, claimed TIA concentration is 250 ng/μL). n = 3.
RT (min)(RSD)
Area(RSD)
Width(min)
% Amount
± SDK ‘ R
(RSD) α As N
12.31(0.14)
1397070(0.06)
0.83 48.60±0.01
5.15 1.11 20393
21.37(0.02)
694064(0.88)
0.70 7.32±1.02
9.68 11.82(0.02)
1.88 1.32 107053
28.05(0.27)
1759762(0.75)
1.07 18.55±0.68
13.03 7.57(0.26)
1.35 1.29 59909
29.17(0.15)
601828(0.58)
0.85 6.34±1.33
13.59 1.17(0.12)
1.04 1.19 152496
30.54(0.11)
1794384(0.55)
0.73 18.92±1.20
14.27 1.73(0.08)
1.05 1.20 157276
32.57(1.20)
18284(1.00)
0.47 0.19±0.66
15.28 3.37(0.95)
1.07 1.13 189448
33.49(0.02)
7442(0.65)
0.38 0.08±0.34
15.74 2.17(0.01)
1.03 1.03 191957
* k’ capacity factor; α, selectivity coefficient; R, resolution; and As, peak asymmetry; N, USP plate count.
Analytical Method Performance
How to present the analytical HPLC method PERFORMANCE PARAMETERS
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Stability studies should include testing of those attributes of the FPP that are susceptible to change during storage and are likely to influence quality, safety and/or efficacy. For instance, in case of tablets:
♦ appearance ♦ hardness ♦ friability ♦ moisture content ♦ dissolution time ♦ degradants♦ assay ♦ microbial purity
STABILITY-INDICATING QUALITY PARAMETERS What are the
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Design
Batch size3 batchesSampling protocol
Before starting program execution we should have;
5 Drug Product
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
How many batches should be tested ?
Batch size = ? Product unit
Which Batches should be tested ?
When should we repeat stability testing?
Selection of batches: Drug product
5
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Selection of batches:
How many batches should be tested ?three, using 3 different batches of starting drug substance
Batch size = ? Product unitTwo pilot scale batches, third smaller if justified)
Which Batches should be tested ?Stability studies should be performed on each individual strength and container size.
When we should repeat stability testing?
[1] In case of failed
stability ..!
[2] Modification?using raw material from different manufacturer, excepients type/ratio change manufacturing procedure modified.change of package, closure.
[3] ApplicationFor ANDA (Pharm. Bioeq) !!
Drug product
5
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
The stability testing should be conducted on the dosage form stored in the proposed containers / closure system for marketing.
Container / closure systems:
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Reference Standards
Design
Purchase USP / Europ. Reference Standard)Purchase Potential ImpuritiesStored in Special Storage cabinet + log book (amount used, when, for what?)Verified (Melting point, IR, HPLC-RT as per USP/BP)
Before starting program execution we should have;
6
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Major Variables
TemperatureRelative HumidityLight (Photostability)
Stability after Reconstitution (dilution)
Sta
bilit
y S
tudy
and
Exp
iratio
n da
teTypical storage condition and study duration
[a] General Case (PERMEABLE)
[b] Drug Products packaged in IMPERMEABLE containers
[c] Drug Products packaged in SEMIPERMEABLE containers
[d] Drug Products intended for storage in refrigerator
[e] Drug Products intended for storage in freezer
[f] Drug Products intended for storage below -20 ºC
Sta
bilit
y S
tudy
and
Exp
iratio
n da
teTypical storage condition and study duration
Study Storage condition Minimum time period
Frequency of sampling (months)
Long-term252C / 60 % RH 5% RH
or302C / 65 % RH 5% RH
12 months 0,3,6,9,12,18,24
Intermediate 302C / 65 % RH 5% RH 6 months 0,3,6,12
Accelerated 402C / 75 % RH 5% RH 6 months 0,1,2,3,6
[a] General Case (PERMEABLE containers to moisture)
• It is up to the applicant to decide the tem/RH for long term.• If 302C / 65 % RH 5% RH is the long term, then NO INTERMEDIATE cond.
Sta
bilit
y S
tudy
and
Exp
iratio
n da
teTypical storage condition and study duration
Study Storage condition Minimum time period
Frequency of sampling (months)
Long-term252C
or302C
12 months 0,3,6,9,12,18,24
Intermediate 302C 6 months 0,3,6,12
Accelerated 402C 6 months 0,1,2,3,6
[b] Drug product packaged in IMPERMEABLE containers (to moisture or solvent loss)
Sensitivity to moisture or potential for solvent loss is not a concern for drug products packaged in impermeable containers that provide a permanent barrier to passage of moisture or solvent.
Thus, stability studies for products stored in impermeable containers can be conducted under any controlled or ambient humidity condition.
Sta
bilit
y S
tudy
and
Exp
iratio
n da
teTypical storage condition and study duration
Study Storage condition Minimum time period
Frequency of sampling (months)
Long-term252C / 40% RH 5% RH
or302C / 35% RH 5% RH
12 months 0,3,6,9,12,18,24
Intermediate 302C / 65 % RH 5% RH 6 months 0,3,6,12
Accelerated 402C / NMT 25 % RH 6 months 0,1,2,3,6
[c] Drug products stored in SEMIPERMEABLE containers
• It is up to the applicant to decide the tem/RH for long term.• If 302C / 35% RH 5% RH is the long term, then NO INTERMEDIATE cond.
Aqueous-based products packaged in semipermeable containers should be evaluated for potential water loss in addition to physical, chemical, biological, and microbiological stability.
5% loss of water (after 3 months) is considered significant change.
Sta
bilit
y S
tudy
and
Exp
iratio
n da
teTypical storage condition and study duration
Study Storage condition Minimum time period
Frequency of sampling (months)
Long-term 5 3C 12 months 0,3,6,9,12,18,24
Accelerated 252C / 60 % RH 5% RH 6 months 0,1,2,3,6
[d] Drug products intended for storage in a REFRIGERATOR
[e] Drug products intended for storage in FREEZER
Study Storage condition Minimum time period
Frequency of sampling (months)
Long-term -20 5C 12 months 0,3,6,9,12,18,24
[f] Drug products intended for storage BELOW -20 C
Drug products intended for storage below -20°C should be treated on a case-by-case basis.
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
THE SIGNIFICANT CHANGES
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
THE SIGNIFICANT CHANGE IS DEFINED AS
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
• The assay value is still within the limits but the change during stability is more than 5.0%
• Example– Release assay limit: 95.0 – 105.0%– Release assay: 101.0% (within spec)– 6-Month assay: 95.5% (within spec)– Loss in potency: 5.5%.– This is a significant change.
EXAMPLE OF FAILED STABILITY
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Stability Data and Report
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
attaché Real Chromatograms attaché RecordsEx: Karl fisher data, tablet weight. .
Attaché auto dissolution readings Attaché Cabinet temp./RH chart data.
Batches testedProduct name.Name and potency of active ingredient.Validated Stability indicating assay methodBatch size.Batch number.Manufacturing site.Manufacturing date.Date stability study was started.Date sample(s) was withdrawn from chamber.
Date of sample analysis.Storage conditions (e.g., 40C / 75% RH).Container / closure system.Supplier and manufacturer of active ingredient(s).Supplier and manufacturer of container / closure system.Supplier and manufacturer of packaging components, cartons, etc.Cumulative tabulation of all tests result.
Literature review Records, reports, and certificates
Conclusion, QA approval and Decision
Stability Data and Report
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
Additional or New Stability Data is Required if;
• Change in the route of synthesis of an API • Change in composition of the FPP• Change in immediate packaging of the FPP
• In case of failed stability, (chemical, instrumental, regulatory)
• using raw material from different manufacturer, • excepients type/ratio change • manufacturing procedure modified.• change of package, closure.
Sta
bilit
y S
tudy
and
Exp
iratio
n da
te
العالمين رب لله الحمد و
Thank you